Hui Wang
Directeur/Membre du Conseil chez Hebei Zhongnuo Pharmaceutical Technology Co., Ltd.
Fortune : 83 565 $ au 30/04/2024
Profil
Hui Wang is currently working as an Executive Director & Manager at Hebei Zhongnuo Pharmaceutical Technology Co., Ltd.
Prior to this, Mr. Wang worked as a Director at CSPC Innovation Pharmaceutical Co., Ltd.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/09/2023 | 17 658 ( 0,01% ) | 83 565 $ | 30/04/2024 |
Postes actifs de Hui Wang
| Sociétés | Poste | Début |
|---|---|---|
Hebei Zhongnuo Pharmaceutical Technology Co., Ltd.
 Hebei Zhongnuo Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of CSPC Pharmaceutical Group Ltd., Hebei Zhongnuo Pharmaceutical Technology Co., Ltd. manufactures and distributes pharmaceutical products. The company is based in Shijiazhuang, China. The Chinese company was founded in 2020. Hebei Zhongnuo Pharmaceutical Technology Co. was acquired by CSPC NBP Pharmaceutical Co., Ltd. from CSPC Innovation Pharmaceutical Co., Ltd. on May 08, 2021 for $18.71 million. | Directeur/Membre du Conseil | - |
Anciens postes connus de Hui Wang
| Sociétés | Poste | Fin |
|---|---|---|
| CSPC INNOVATION PHARMACEUTICAL CO., LTD. | Directeur/Membre du Conseil | 12/04/2023 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CSPC INNOVATION PHARMACEUTICAL CO., LTD. | Consumer Non-Durables |
| Entreprise privées | 1 |
|---|---|
Hebei Zhongnuo Pharmaceutical Technology Co., Ltd.
Hebei Zhongnuo Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of CSPC Pharmaceutical Group Ltd., Hebei Zhongnuo Pharmaceutical Technology Co., Ltd. manufactures and distributes pharmaceutical products. The company is based in Shijiazhuang, China. The Chinese company was founded in 2020. Hebei Zhongnuo Pharmaceutical Technology Co. was acquired by CSPC NBP Pharmaceutical Co., Ltd. from CSPC Innovation Pharmaceutical Co., Ltd. on May 08, 2021 for $18.71 million. | Health Technology |